PERSPECTA

News from every angle

Back to headlines

Singapore Biotech Mirxes Delays Results After Audit Issues

Singaporean biotech company Mirxes has postponed the release of its results in Hong Kong after an audit flagged several issues.

4 Apr, 11:45 — 4 Apr, 11:45
PostShare